December 2011 Research News


Breast Cancer Radiation Therapy Linked to Narrowing of Coronary Arteries
December 29, 2011
A large study found women who'd received radiation therapy to treat early-stage breast cancer were more likely to have narrowing or blockage of the coronary arteries compared to women who hadn't received radiation therapy for breast cancer. Read more...

Many Women Treated with Brachytherapy Aren’t Good Candidates
December 19, 2011
A large study has found that many women treated with brachytherapy were not good candidates for that form of radiation therapy based on the characteristics of the breast cancer with which they were diagnosed. Read more...

When Breast Cancer Doctors Collaborate, Women More Satisfied
December 16, 2011
A study found that women whose doctors actively collaborated throughout the course of breast cancer treatment were more satisfied with their treatment than women whose doctors didn't collaborate. Read more...

Oral Bisphosphonates Don’t Seem to Reduce Recurrence Risk
December 12, 2011
Two studies found that two oral bisphosphonates didn't reduce recurrence risk for women diagnosed with early-stage breast cancer. Read more...

New Doxorubicin Formula May Be Safer for Heart Than Traditional Formulas
December 12, 2011
A small study suggests that a new formulation of the chemotherapy medicine doxorubicin may be safer for the heart than traditional formulations. Read more...

Afinitor Before Surgery Doesn’t Help Treat HER2-Negative Breast Cancer
December 11, 2011
Research has found that adding Afinitor to paclitaxel didn't improve the response to neoadjuvant treatment with paclitaxel in women diagnosed with advanced-stage, HER2-negative breast cancer. Read more...

Zometa Can Help Reduce Recurrence Risk of Hormone-Receptor-Positive Disease
December 10, 2011
Results from three studies all suggest that Zometa can help reduce the risk of cancer recurrence when it's started right after surgery to treat hormone-receptor-positive early-stage breast cancer in postmenopausal and older premenopausal women. Read more...

Preventively Removing Ovaries May Reduce Bone Density
December 9, 2011
Research suggests that premenopausal women who have preventive oophorectomy to reduce breast cancer risk may be more likely to have low bone mineral density and arthritis. Read more...

Women with Abnormal BRCA Gene Have Higher Risk of New Cancer in Opposite Breast
December 9, 2011
Research shows that women with an abnormal BRCA1 or BRCA2 gene who've been diagnosed with breast cancer have a higher risk of being diagnosed with a new, different cancer in the opposite breast compared to women without an abnormal BRCA1 or BRCA2 gene. Read more...

Removing Breast Tumor May Improve Survival When Metastatic Disease is First Diagnosis
December 9, 2011
A small study has found that women diagnosed with metastatic breast cancer (with no previous history of early-stage breast cancer) who had surgery to remove the primary tumor in the breast lived longer after diagnosis than women who didn't have the primary tumor removed. Read more...

Adding Avastin Slows Growth of Metastatic, HER2-Positive Disease
December 8, 2011
A study has found that adding Avastin to a combination of Herceptin and Taxotere increased the likelihood of responding to treatment and the time women diagnosed with locally advanced and metastatic HER2-positive breast cancer lived without the cancer growing compared to women treated with only Herceptin and Taxotere. Read more...

Heart Problems Caused by Herceptin May Be More Common Than Thought
December 8, 2011
A small study has found that after 3 months of Herceptin treatment nearly 58% of women had some loss of heart function. Read more...

Experimental Omnitarg May Help Treat Metastatic, HER2-Positive Disease
December 8, 2011
Research suggests that adding the experimental medicine Omnitarg to a combination of Herceptin and Taxotere slows the growth of metastatic HER2-positive breast cancer more than Herceptin and Taxotere alone. Read more...

Arimidex-Faslodex Combo Improves Survival in Metastatic Breast Cancer
December 8, 2011
A study has found that postmenopausal women diagnosed with hormone-receptor-positive metastatic breast cancer and treated with a combination of Arimidex and Faslodex as the first treatment for metastatic disease lived 6 months longer than women treated only with Arimidex. Read more...

Experts Release Report Detailing Environmental Breast Cancer Risks
December 7, 2011
An expert report says that combination HRT, being overweight after menopause, and drinking alcohol are definitely linked to higher breast cancer risk. Read more...

Afinitor Helps Slow Growth of Certain Advanced-Stage Breast Cancers
December 7, 2011
New information from the BOLERO-2 study shows that women diagnosed with hormone-receptor-positive, HER2-negative advanced-stage or metastatic breast cancer who got Afinitor and Aromasin in combination lived more than twice as long without the cancer growing than women who got only Aromasin. Read more...

OncotypeDx Test Can Help Decide if Radiation Needed After DCIS Surgery
December 7, 2011
The OncotypeDx test can help doctors decide if women diagnosed with DCIS need radiation therapy. Read more...

Research Finds Links Between Obesity, Diabetes and Breast Cancer
December 6, 2011
A very large study has found links between higher breast cancer risk and diabetes and obesity. Read more...

Brachytherapy May Not Be as Effective as Whole-Breast Radiation in Reducing Recurrence Risk
December 6, 2011
Results from a large study suggest that brachytherapy may not be as effective as whole-breast radiation therapy at preventing breast cancer recurrence. Read more...

Xgeva More Likely to Cause Osteonecrosis of the Jaw in Women Diagnosed with Advanced-Stage Breast Cancer
December 2, 2011
Research suggests that people diagnosed with advanced-stage breast or prostate cancer who get Xgeva are about twice as likely to develop osteonecrosis of the jaw compared to people with other advanced-stage cancers treated with Xgeva. Read more...

Fracture Risk in Younger Women Being Treated for Breast Cancer Higher Than Thought
December 1, 2011
A study found that about 16% of premenopausal women treated for early-stage breast cancer broke a bone during treatment or in the years after treatment; this rate was 60% higher than expected. Read more...

Was this resource helpful?

Yes No
C3a
C3b
Evergreen-donate
Back to Top